Outcome analysis of acute myeloid leukemia patients treated with high dose daunorubicin. Biomed. Res. Ther. [Internet]. 2019 Sep. 10 [cited 2025 Apr. 7];6(9):3347-51. Available from: https://preservation.bmrat.org/index.php/BMRAT/article/view/562